History of Arvind Remedies Ltd.

The Comp. was incorporated on 17.6.1988 as a private limited Comp. under the name Arvind Remedies Pvt. limited Subsequently it was converted into a public limited Comp. by passing a special resolution 7th April 1995 & obtaining a fresh certificate of incorporation on 18th May 1995 & consequently the name change.

EXISTING BUSINESS

The Registered Office & the factory of Comp. measuring 4,400 sq.ft. are located at 25/9 Nelson Manickam Road, Mehta Nagar, Madras 600 029. For the above purpose the Comp. has entered into a five year lease agreement with Mr. O.M. Shahul Ameed & Syed Ahmed. The monthly lease rent is Rs.15,400 & an advance of Rs.75,000 was paid for the same. The Comp. has a depot measuring 2500 sq.ft. at 23/1 Railway Colony, II Street, Madras - 29 & the premises has been taken on lease from Deluxe Tools and Moulders. The monthly lease rent is Rs.7,500 & an advance of Rs.30,000 was paid for same.

The Comp. is presently having production facilities for manufacturing tablets & capsules. This is located at Nelson Manickam Road, Aminjikarai, Madras.

The existing manufacturing unit possesses a valid manufacturing licence & is approved by Drugs Directorate far Good Manufacturing Practice [G.M.P.s] Certificate as per the norms of World Health Organisation [W.H.O.s].

The Comp. started its operations with 6 products for supply to Institutions like Directorate of Medical Service of Tamil Nadu, Directorate of Preventive & Primary Health Centre, Tamil Nadu, Government of Medical Stores, Hyderabad, & other Government Institutions in Kerala & Karnataka.

It has since then expanded its operations & today manufactures over 80 products in various segments like ethical, generic & exports besides Institutions in the South.

There has been no labour problems or closures in the past.

1996

-Arvind Remedies has offered a safety net for its prospective investors.

2001 - Right issue of 14,86,000 No. of Equity Shares of Rs 10/- each at a premium of Rs 90/- per share in the ratio of one equity share for every four equity shares held aggregating Rs 14.86 crores.

2003

-Successfully launched two herbal products recently throughout India viz. Pankare & Sorexil

-Board approved the equity preferential allotment of USD 10 million to Citiconsult Emerging Markets, UK.

-Board approves FIIs to invest upto 24% in the equity of company